Not-So-Sweet Dreams: Plasma and IgG N-Glycome in the Severe Form of the Obstructive Sleep Apnea

Overview

Journal Biomolecules

Publisher MDPI

Specialties Biochemistry
Molecular Biology

Date 2023 Jun 28

PMID 37371460

Authors

Doris Plecas

Nikol Mraz

Anne Marie Patanaude

Tea Pribic

Ivana Pavlinac Dodig

Renata Pecotic

Gordan Lauc

Ozren Polasek

Zoran Dogas

Affiliations

Soon will be listed here.

Abstract

Obstructive sleep apnea (OSA) is a prevalent disease associated with increased risk for cardiovascular and metabolic diseases and shortened lifespan. The aim of this study was to explore the possibility of using N-glycome as a biomarker for the severe form of OSA. Seventy subjects who underwent a whole-night polysomnography/polygraphy and had apnea-hypopnea index (AHI) over 30 were compared to 23 controls (AHI under 5). Plasma samples were used to extract 39 glycan peaks using ultra-high-performance liquid chromatography (UPLC) and 27 IgG peaks using capillary gel electrophoresis (CGE). We also measured glycan age, a molecular proxy for biological aging. Three plasma and one IgG peaks were significant in a multivariate model controlling for the effects of age, sex, and body mass index. These included decreased GP24 (disialylated triantennary glycans as major structure) and GP28 (trigalactosylated, triantennary, disialylated, and trisialylated glycans), and increased GP32 (trisialylated triantennary glycan). Only one IgG glycan peak was significantly increased (P26), which contains biantennary digalactosylated glycans with core fucose. Patients with severe OSA exhibited accelerated biological aging, with a median of 6.9 years more than their chronological age ( < 0.001). Plasma N-glycome can be used as a biomarker for severe OSA.

References

Marrone O, Lo Bue A, Salvaggio A, Dardanoni G, Insalaco G . Comorbidities and survival in obstructive sleep apnoea beyond the age of 50. Eur J Clin Invest. 2012; 43(1):27-33. DOI: 10.1111/eci.12011. View

Adua E, Afrifa-Yamoah E, Peprah-Yamoah E, Anto E, Acheampong E, Awuah-Mensah K . Multi-block data integration analysis for identifying and validating targeted N-glycans as biomarkers for type II diabetes mellitus. Sci Rep. 2022; 12(1):10974. PMC: 9243128. DOI: 10.1038/s41598-022-15172-z. View

Wittenbecher C, Stambuk T, Kuxhaus O, Rudman N, Vuckovic F, Stambuk J . Plasma -Glycans as Emerging Biomarkers of Cardiometabolic Risk: A Prospective Investigation in the EPIC-Potsdam Cohort Study. Diabetes Care. 2020; 43(3):661-668. DOI: 10.2337/dc19-1507. View

Vergroesen R, Slot L, van Schaik B, Koning M, Rispens T, van Kampen A . -Glycosylation Site Analysis of Citrullinated Antigen-Specific B-Cell Receptors Indicates Alternative Selection Pathways During Autoreactive B-Cell Development. Front Immunol. 2019; 10:2092. PMC: 6749139. DOI: 10.3389/fimmu.2019.02092. View

Verhelst X, M Dias A, Colombel J, Vermeire S, Van Vlierberghe H, Callewaert N . Protein Glycosylation as a Diagnostic and Prognostic Marker of Chronic Inflammatory Gastrointestinal and Liver Diseases. Gastroenterology. 2019; 158(1):95-110. DOI: 10.1053/j.gastro.2019.08.060. View

Papanas N, Steiropoulos P, Nena E, Tzouvelekis A, Maltezos E, Trakada G . HbA1c is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men. Vasc Health Risk Manag. 2009; 5:751-6. PMC: 2747393. DOI: 10.2147/vhrm.s7057. View

Marshall N, Wong K, Cullen S, Knuiman M, Grunstein R . Sleep apnea and 20-year follow-up for all-cause mortality, stroke, and cancer incidence and mortality in the Busselton Health Study cohort. J Clin Sleep Med. 2014; 10(4):355-62. PMC: 3960375. DOI: 10.5664/jcsm.3600. View

Larsen M, de Graaf E, Sonneveld M, Plomp H, Nouta J, Hoepel W . Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity. Science. 2020; 371(6532). PMC: 7919849. DOI: 10.1126/science.abc8378. View

He J, Kryger M, Zorick F, Conway W, Roth T . Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest. 1988; 94(1):9-14. View

10.

Knezevic A, Polasek O, Gornik O, Rudan I, Campbell H, Hayward C . Variability, heritability and environmental determinants of human plasma N-glycome. J Proteome Res. 2008; 8(2):694-701. DOI: 10.1021/pr800737u. View

11.

Suhre K, Trbojevic-Akmacic I, Ugrina I, Mook-Kanamori D, Spector T, Graumann J . Fine-Mapping of the Human Blood Plasma N-Glycome onto Its Proteome. Metabolites. 2019; 9(7). PMC: 6681129. DOI: 10.3390/metabo9070122. View

12.

Kristic J, Vuckovic F, Menni C, Klaric L, Keser T, Beceheli I . Glycans are a novel biomarker of chronological and biological ages. J Gerontol A Biol Sci Med Sci. 2013; 69(7):779-89. PMC: 4049143. DOI: 10.1093/gerona/glt190. View

13.

Colombo M, Asadi Shehni A, Thoma I, McGurnaghan S, Blackbourn L, Wilkinson H . Quantitative levels of serum N-glycans in type 1 diabetes and their association with kidney disease. Glycobiology. 2020; 31(5):613-623. DOI: 10.1093/glycob/cwaa106. View

14.

Hu M, Lan Y, Lu A, Ma X, Zhang L . Glycan-based biomarkers for diagnosis of cancers and other diseases: Past, present, and future. Prog Mol Biol Transl Sci. 2019; 162:1-24. DOI: 10.1016/bs.pmbts.2018.12.002. View

15.

Stazic P, Roguljic M, Dogas Z, Lusic Kalcina L, Pavlinac Dodig I, Valic M . Periodontitis severity in obstructive sleep apnea patients. Clin Oral Investig. 2021; 26(1):407-415. DOI: 10.1007/s00784-021-04012-5. View

16.

Haakensen V, Steinfeld I, Saldova R, Asadi Shehni A, Kifer I, Naume B . Serum N-glycan analysis in breast cancer patients--Relation to tumour biology and clinical outcome. Mol Oncol. 2015; 10(1):59-72. PMC: 5528923. DOI: 10.1016/j.molonc.2015.08.002. View

17.

Mattei A, Tabbia G, Baldi S . Diagnosis of sleep apnea. Minerva Med. 2004; 95(3):213-31. View

18.

Veerman J . Unexpected survival of people with sleep apnoea: parallels in obesity research. J Sleep Res. 2010; 19(1 Pt 2):255. DOI: 10.1111/j.1365-2869.2009.00803.x. View

19.

Pecotic R, Pavlinac Dodig I, Valic M, Galic T, Lusic Kalcina L, Ivkovic N . Effects of CPAP therapy on cognitive and psychomotor performances in patients with severe obstructive sleep apnea: a prospective 1-year study. Sleep Breath. 2018; 23(1):41-48. DOI: 10.1007/s11325-018-1642-6. View

20.

Malhotra A, Ayappa I, Ayas N, Collop N, Kirsch D, McArdle N . Metrics of sleep apnea severity: beyond the apnea-hypopnea index. Sleep. 2021; 44(7). PMC: 8271129. DOI: 10.1093/sleep/zsab030. View